FIELD: pharmaceutical chemistry. SUBSTANCE: invention provides antiallergenic and antiinflammatory agent of formula I: (I). EFFECT: reduced toxicity. 1 tbl
Title | Year | Author | Number |
---|---|---|---|
ANTIALLERGIC AND ANTI-IFLAMMATORY AGENT | 1999 |
|
RU2170091C2 |
2-HYDROXY-3-METHOXYBENZALDEHYDE ISONICOTINOYL HYDRAZONE SHOWING ANTIASTHMATIC, ANTI-INFLAMMATORY AND ANTI-ALLERGIC ACTIVITY | 1997 |
|
RU2139711C1 |
5-ETHYL-2-AMINO-1,3,4-THIADIAZOLE DERIVATIVES WITH ANESTHETIC, ANTI-INFLAMMATORY, ANTI-ALLERGIC AND ANALGETIC ACTIVITY | 2016 |
|
RU2651572C2 |
MONO- OR DICARBOXYLIC ACID ZINC SALTS SHOWING GASTROPROTECING ACTIVITY | 1995 |
|
RU2116292C1 |
INHALATION COMPOSITION FOR BRONCHIAL ASTHMA TREATMENT | 1992 |
|
RU2054932C1 |
MAGNESIUM 5-HYDROXYNICOTINATE SHOWING COMPLEX ANTIDIABETIC EFFECT | 1998 |
|
RU2136663C1 |
DERIVATIVES OF 2-(3,4-DIHYDROXYPHENYL) ETHYLAMINE SHOWING IMMUNOTROPIC ACTIVITY AND CAPABILITY TO INHIBIT VIRUS REPLICATION | 1992 |
|
RU2039733C1 |
PHARMACEUTICAL COMPOSITION WITH ANTI-ALLERGIC AND ANTI-INFLAMMATORY ACTION | 2006 |
|
RU2308272C1 |
1-BENZYL-2-OXOTRYPTAMINE HYDROCHLORIDE AND ITS DERIVATIVES SHOWING HEPATOPROTECTIVE ACTIVITY | 1994 |
|
RU2084449C1 |
METHOD OF EVALUATION OF ORGANISM' STRENGTH TO EFFECT OF EXOGENIC FACTORS | 1992 |
|
RU2068231C1 |
Authors
Dates
2000-12-10—Published
1999-07-27—Filed